Research on GLP-1, GIP, and glucagon receptor agonists showing metabolic effects in preclinical and clinical studies. For in vitro research purposes only.
Dual GIP/GLP-1 receptor agonist — mechanism of action, research findings, and current study status.
Triple GLP-1/GIP/glucagon receptor agonist — what preclinical and clinical research shows so far.
Long-acting GLP-1 receptor agonist with demonstrated metabolic effects in research settings.
Head-to-head comparison of dual vs single receptor agonism, efficacy data, and research findings.
Amylin/calcitonin receptor agonist — mechanism and research applications in metabolic studies.
Emerging dual agonist research — current preclinical data and mechanism overview.
Disclaimer: All peptides discussed are for in vitro laboratory research only and are not approved for human consumption. Consult institutional and regulatory guidelines before conducting research.
All weight loss research compounds available at ≥99% purity with CoA included.
Browse Products →